BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32665994)

  • 21. Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series.
    Simone G; Tuderti G; Misuraca L; Anceschi U; Ferriero M; Minisola F; Guaglianone S; Gallucci M
    Eur J Surg Oncol; 2018 Sep; 44(9):1432-1438. PubMed ID: 29699838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage.
    Buchner A; Grimm T; Schneevoigt BS; Wittmann G; Kretschmer A; Jokisch F; Grabbert M; Apfelbeck M; Schulz G; Gratzke C; Stief CG; Karl A
    Scand J Urol; 2017 Apr; 51(2):130-136. PubMed ID: 28332428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
    Lee JS; Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Korean J Urol; 2015 Apr; 56(4):295-304. PubMed ID: 25874043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
    Grimm T; Buchner A; Schneevoigt B; Kretschmer A; Apfelbeck M; Grabbert M; Jokisch JF; Stief CG; Karl A
    World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
    Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
    Necchi A; Pond GR; Smaldone MC; Pal SK; Chan K; Wong YN; Viterbo R; Sonpavde G; Harshman LC; Crabb S; Alva A; Chowdhury S; De Giorgi U; Srinivas S; Agarwal N; Bamias A; Baniel J; Golshayan AR; Ladoire S; Sternberg CN; Cerbone L; Yu EY; Bellmunt J; Vaishampayan U; Niegisch G; Hussain S; Bowles DW; Morales-Barrera R; Milowsky MI; Theodore C; Berthold DR; Sridhar SS; Powles T; Rosenberg JE; Galsky MD;
    Eur Urol Focus; 2018 Dec; 4(6):937-945. PubMed ID: 28753879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of metastatic burden in cytoreductive/consolidative radical cystectomy.
    Li R; Kukreja JEB; Seif MA; Petros FG; Campbell MT; Nguyen JV; González GMN; Kamat AM; Pisters LL; Dinney CP; Navai N
    World J Urol; 2019 Dec; 37(12):2691-2698. PubMed ID: 30864005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
    Morgan TM; Barocas DA; Chang SS; Phillips SE; Salem S; Clark PE; Penson DF; Smith JA; Cookson MS
    Urol Oncol; 2013 Aug; 31(6):871-7. PubMed ID: 21906965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Yao Z; Jiang Y; Zhu X; Wu B; Bai S
    Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
    Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center.
    Chipollini J; Alford B; Boulware DC; Forget P; Gilbert SM; Lockhart JL; Pow-Sang JM; Sexton WJ; Spiess PE; Poch MA; Patel SY
    BMC Anesthesiol; 2018 Nov; 18(1):157. PubMed ID: 30390636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.